Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2004-03-05
2009-10-13
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S007200, C536S007400
Reexamination Certificate
active
07601695
ABSTRACT:
Described herein are novel macrolides, the preparation of novel macrolides, to the use of novel macrolides for preventing, treating, or ameliorating various conditions, and the use of novel macrolides as antibacterial agents.
REFERENCES:
patent: 4331803 (1982-05-01), Watanabe et al.
patent: 4474768 (1984-10-01), Bright
patent: 4742049 (1988-05-01), Baker et al.
patent: 5635485 (1997-06-01), Agouridas et al.
patent: 5656607 (1997-08-01), Agouridas et al.
patent: 5747467 (1998-05-01), Agouridas et al.
patent: 5760233 (1998-06-01), Agouridas et al.
patent: 5770579 (1998-06-01), Agouridas et al.
patent: 6011142 (2000-01-01), Bonnet et al.
patent: 6028181 (2000-02-01), Or et al.
patent: 6395710 (2002-05-01), Chu et al.
patent: 6407074 (2002-06-01), Bronk et al.
patent: 6420535 (2002-07-01), Phan et al.
patent: 6437106 (2002-08-01), Stoner et al.
patent: 6440941 (2002-08-01), Denis
patent: 6455505 (2002-09-01), Agouridas et al.
patent: 6664238 (2003-12-01), Su et al.
patent: 6890907 (2005-05-01), Speirs et al.
patent: 2002/0028781 (2002-03-01), Agouridas et al.
patent: 2005/0153905 (2005-07-01), Burger et al.
patent: 2005/0222427 (2005-10-01), Sharpless et al.
patent: WO 99/21866 (1999-05-01), None
patent: WO 00/44761 (2000-08-01), None
patent: WO 00/62783 (2000-10-01), None
patent: WO 02/50092 (2002-06-01), None
Baker, W.R. et al., J. Org. Chem., 53:2340-2345 (1988).
Djokic, S. et al., J. Chem. Soc., Perkin Trans 1., 1881 (1986).
Phan, L.T. et al., Org. Ltrs., 2:2951-2954 (2000).
Or et al., “Design, Synthesis, and Antimicrobial Activity of 6-0-Substituted Ketolides Active Against Resistant Respiratory Tract Pathogens”,J. Med. Chem.,43:1045-49 (2000).
Champney et al., “Structure-Activity Relationships for Six Ketolide Antibiotics”,Current Microbiology,42:203-10 (2001).
Denis et al., β-Keto-Ester Chemistry and Ketolides. Snythesis and antibacterial Activity of 2-Halogeno, 2-Methyl and 2,3 Enol-Ether Ketolides,Bioorganic&Medicinal Chemistry Letters,10:2019-22 (2000).
Tornøe et al. “Peptidotriazoles on Solid Phase: [1,2,3]-Triazoles by Regiospecific Copper(l)-Catalyzed 1,3-Dipolar Cycloadditions of Terminal Alkynes to Azides”,J. Org. Chem.,67:3057-64 (2002).
Physicians' Desk Reference, p. 2905, (2007).
LeMahieu, R. A., Carson, M., and Kierstead, R. W., “Glycoside Cleavage Reactions on erythromycin A. Preparation of Erythronolide A”, Journal of Medicinal Chemistry, vol. 17, No. 9, 1974, 953-956.
Romero, A., Liang, C.-H., Chiu, Y.-H., Yao, S., Duffield, J., Sucheck, S. J., Marby, K., Rabuka, D., Leung, P. Y., Shue, Y.-K., Ishikawa, and Y., Hueng, C.-K., An Efficient Entry to New Sugar Modified Ketolide.
Birkenmeyer, R. D., Kroll, S. J., Lewis, C., Stern, K. F., and Zurenko, G. E., “Synthesis and Antibacterial Activity of Clindamycin Analogues: Pirlimycin, a Potent Antibacterial Agent”, Journal of Medicinal Chemistry, vol. 27, No. 2, 1984, 216-223.
Vince, R., Almquist, R. G., Ritter, C. L., and Daluge, S., Antimicrobial Agents and Chemotherapy, vol. 8, No. 4, 1975, 439-443.
Chiu Yu-Hung
Duffield Jonathan
Hwang Chan-Kou
Ichikawa Yoshi
Liang Chang-Hsing
Barnes & Thornburg LLP
Optimer Pharmaceuticals, Inc.
Peselev Elli
LandOfFree
Antibacterial agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibacterial agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibacterial agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4112528